What is the main business of Pexon Poland?

The main business activity of Pexon Poland focuses on manufacture of basic pharmaceutical products.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 13, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Tomasza Zana 11A, 20-601 Lublin.

Who is on the management board?

The management board consists of: Karolina Szczygielska (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of $122,616 in 2025, which is an increase of 39.7% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $6,229, meaning the company decreased its profit by 77.6%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $63,767 in 2025, representing 56% of all operating expenses.

Pexon Polandsp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-03-13

Share capital

5 000,00 PLN

Activity description

Pexon Poland is a pharmaceutical company that offers products and services in the pharmaceutical, food, and technology sectors. It specializes in product development and services, ranging from research and development to market positioning.

Registered address

ul. Tomasza Zana 11A, 20-601 Lublin, Poland

Website

pexon.pl

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 122.62kMedianUSD 109.30kAverageUSD 2.05m

Net profit

This companyUSD 6.23kMedianUSD -146.00AverageUSD 68.27k

Operating costs

This companyUSD 114.71kMedianUSD 161.19kAverageUSD 1.90m

Assets

This companyUSD 105.30kMedianUSD 124.37kAverageUSD 1.41m

Industry

Bank accounts

Registered as a VAT taxpayer on 2023-05-01. Active

PKO Bank Polski
02 1020 1026 0000 1402 0575 5030
PKO Bank Polski
33 1020 1127 0000 1002 0429 9517

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Karolina Szczygielska — President of the Management Board

Rafał Wojciech Pieczka — Attorney-in-fact (sole)

Manner of representation

The following are authorised to make all declarations of will on behalf of the company: A. in the case of a one-person management board – the member of the management board independently; B. in the case of a multi-member management board – two members of the management board jointly or a member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Karolina Szczygielska (45)	91	$1,229.07	91%
Others	9	$121.56	9%

Beneficial owners

Person	Rights
Karolina Szczygielska (45)	Shareholder of a limited liability company, 4550.0 PLN

Competitors

Name	Revenue	Website
Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o.	$1,184,204.34	labor.com.pl
F1 PharmaS.A.	$272,113.66	f1pharma.pl
Ampliconsp. z o.o.	$48,330.99	amplicon.pl

Change history

Date	Event
2023-03-23	Address change (Ul. Tomasza Zana 11, 20-601, Lublin → Ul. Tomasza Zana 11a, 20-601, Lublin)
2023-03-13	Entered in the register

FAQ

Last updated: 2026-07-29